All the news Showing 10 of 62 articles from: Treatment for people who use drugsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Indonesian buyers club helps people obtain generic hepatitis C treatment Liz Highleyman / 30 May 2017 A community-led buyers club in Indonesia has helped more than 100 people get generic direct-acting antiviral (DAA) drugs to treat hepatitis C and is seeing a high cure rate, according to a ... Hepatitis C virus reinfection is uncommon after being cured with DAAs Liz Highleyman / 22 May 2017 Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during three years of follow-up, researchers reported ... Hepatitis C treatment can be provided successfully at syringe programme sites Liz Highleyman / 18 April 2017 Administering direct-acting antiviral therapy for people who inject drugs at a syringe exchange site led to high sustained response rates in a pilot study in New York City, researchers reported at the recent ... Sofosbuvir-based therapy achieves excellent SVR12 rates among people who inject drugs in Ukraine Michael Carter / 05 December 2016 People who inject drugs (PWID) can have an excellent response to sofosbuvir-based therapy for hepatitis C virus (HCV) infection, Ukrainian research presented to the recent 2016 AASLD Liver Meeting shows. Overall, 93% of people had ... EASL issues new hepatitis C treatment recommendations for all genotypes Liz Highleyman / 26 September 2016 The European Association for the Study of the Liver (EASL) released its latest recommendations on treatment of hepatitis C at a special meeting last Thursday in Paris. The updated guidelines now include highly ... HCV treatment is effective and may work as prevention for people who inject drugs Liz Highleyman / 19 September 2016 Hepatitis C treatment for people who inject drugs is as safe and effective as it is for non-drug-users – with cure rates exceeding 90% – and treating enough people in this population could ... Further evidence that interferon-free hepatitis C treatment safe and effective for people who inject drugs Liz Highleyman / 07 September 2016 People with hepatitis C and on opioid substitution therapy, including those who continue to use illicit drugs, maintained good adherence and had high sustained response rates when treated with sofosbuvir/ledipasvir (Harvoni) or sofosbuvir/velpatasvir (Epclusa), according ... Grazoprevir/elbasvir hepatitis C treatment works well for people who inject drugs Liz Highleyman / 14 August 2016 Merck's grazoprevir/elbasvir hepatitis C regimen was well tolerated and cured more than 90% of people who inject drugs receiving opioid substitution therapy, according to results from the C-EDGE CO-STAR study published in ... Only treating patients with cirrhosis with DAAs will have limited impact on HCV epidemic in England Michael Carter / 24 May 2016 Targeting new hepatitis C virus (HCV) direct-acting antivirals (DAAs) at patients with cirrhosis will substantially reduce short-term incidence of end-stage liver disease (ESLD) and liver cancer (HCC) in England, according to a model ... Hepatitis C therapy improves quality of life for people who inject drugs, but reinfection risk remains Liz Highleyman / 06 May 2016 People on opiate substitution therapy can be successfully treated with grazoprevir/elbasvir (Zepatier), leading to improvements in some aspects of quality of life, according to findings from the C-EDGE CO-STAR study presented at ... ← Prev1...34567Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive